| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |